English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/217477
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Extracellular granzyme A promotes colorectal cancer development by enhancing gut inflammation

AuthorsSantiago, Llipsy; Castro, Marta; Sanz-Pamplona, Rebeca; Garzón, Marcela; Ramírez-Labrada, Ariel; Tapia, Elena; Moreno, Víctor; Layunta, Elena; Gil-Gómez, Gabriel; Garrido, Marta; Peña, Raúl; Lanuza, Pilar M.; Comas, Laura; Jaime Sánchez, Paula; Uranga Murillo, Iratxe; del Campo, Rosa; Pelegrín, Pablo; Camerer, Eric; Martínez Lostao, Luis; Muñoz, Guillermo; Uranga, José A.; Alcalde, Anabel ; Gálvez Buerba, Eva Mª ; Ferrández, Ángel; Bird, Phillip I.; Metkar, Sunil; Arias, Maykel; Pardo, Julián
KeywordsGranzyme
Extracellular
Gut
Colorectal cancer
Inflammation
STAT3
IL6
Macrophage
Issue Date7-Jul-2020
PublisherCell Press
Elsevier BV
CitationCell Reports 32(1): 107847 (2020)
AbstractIf not properly regulated, the inflammatory immune response can promote carcinogenesis, as evident in colorectal cancer (CRC). Aiming to gain mechanistic insight into the link between inflammation and CRC, we perform transcriptomics analysis of human CRC, identifying a strong correlation between expression of the serine protease granzyme A (GzmA) and inflammation. In a dextran sodium sulfate and azoxymethane (DSS/AOM) mouse model, deficiency and pharmacological inhibition of extracellular GzmA both attenuate gut inflammation and prevent CRC development, including the initial steps of cell transformation and epithelial-to-mesenchymal transition. Mechanistically, extracellular GzmA induces NF-κB-dependent IL-6 production in macrophages, which in turn promotes STAT3 activation in cultured CRC cells. Accordingly, colon tissues from DSS/AOM-treated, GzmA-deficient animals present reduced levels of pSTAT3. By identifying GzmA as a proinflammatory protease that promotes CRC development, these findings provide information on mechanisms that link immune cell infiltration to cancer progression and present GzmA as a therapeutic target for CRC.
Description8 figures, 1 table.-- Electronic supplementary information available
Publisher version (URL)http://dx.doi.org/10.1016/j.celrep.2020.107847
URIhttp://hdl.handle.net/10261/217477
DOI10.1016/j.celrep.2020.107847
ISSN2211-1247
Appears in Collections:(ICB) Artículos
Files in This Item:
File Description SizeFormat 
j.celrep.2020.107847.pdfArtículo principal5,13 MBAdobe PDFThumbnail
View/Open
j.celrep.2020.107847_info sup.pdfInformación suplementaria2,16 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.